| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |